Evusheld is a medicine used to prevent COVID-19 in adults and adolescents (from 12 years of age weighing at least 40 kilograms). It is also used to treat COVID-19 in adults and adolescents who do not require supplemental oxygen and who are at increased risk of the disease becoming severe. Evusheld contains two active substances, tixagevimab and cilgavimab.
Therapeutic Indication
N/A
Therapeutic Area (MeSH)
ATC Code
N/A
ATC Item
N/A
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| tixagevimab | N/A | Tixagevimab |
| cilgavimab | N/A | Cilgavimab |
EMA Name
Evusheld
Medicine Name
Evusheld
Aliases
N/A